Articles written by: Shane Marler

F5 Networks Inc. (FFIV)’s Financial Results Comparing With Amdocs Limited (NASDAQ:DOX)

Both F5 Networks Inc. (NASDAQ:FFIV) and Amdocs Limited (NASDAQ:DOX) are Business Software & Services companies, competing one another. We will contrast their institutional ownership, earnings and valuation, profitability, risk, dividends, analyst recommendations. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio F5 Networks Inc. 2.18B […]

Repligen Corporation (RGEN)’s Financial Results Comparing With Agios Pharmaceuticals Inc. (NASDAQ:AGIO)

Both Repligen Corporation (NASDAQ:RGEN) and Agios Pharmaceuticals Inc. (NASDAQ:AGIO) are Biotechnology companies, competing one another. We will compare their analyst recommendations, institutional ownership, profitability, risk, dividends, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Repligen Corporation 194.03M 13.98 16.62M 0.37 162.03 […]

Clipper Realty Inc. (CLPR)’s Financial Results Comparing With New Senior Investment Group Inc. (NYSE:SNR)

This is a contrast between Clipper Realty Inc. (NYSE:CLPR) and New Senior Investment Group Inc. (NYSE:SNR) based on their profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation. The two companies are REIT – Diversified and they also compete with each other. Earnings & Valuation Gross Revenue Price/Sales Ratio […]

Unity Biotechnology Inc. (UBX)’s Financial Results Comparing With Quanterix Corporation (NASDAQ:QTRX)

Unity Biotechnology Inc. (NASDAQ:UBX) and Quanterix Corporation (NASDAQ:QTRX), are influenced by contrast since they are both players in the Biotechnology. These factors are particularly influence the risk, analyst recommendations, institutional ownership, profitability, dividends, earnings and valuation of the two firms. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings […]

Arbutus Biopharma Corporation (ABUS)’s Financial Results Comparing With Array BioPharma Inc. (NASDAQ:ARRY)

As Biotechnology companies, Arbutus Biopharma Corporation (NASDAQ:ABUS) and Array BioPharma Inc. (NASDAQ:ARRY) are our subject to contrast. And more specifically their institutional ownership, profitability, risk, dividends, analyst recommendations, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Arbutus Biopharma Corporation 5.95M 34.93 […]

AgeX Therapeutics Inc. (AGE)’s Financial Results Comparing With Puma Biotechnology Inc. (NASDAQ:PBYI)

Both AgeX Therapeutics Inc. (NYSEAMERICAN:AGE) and Puma Biotechnology Inc. (NASDAQ:PBYI) are each other’s competitor in the Biotechnology industry. Thus the contrast of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AgeX Therapeutics Inc. […]

Rafael Holdings Inc. (RFL) and Revance Therapeutics Inc. (NASDAQ:RVNC) Comparing side by side

We will be comparing the differences between Rafael Holdings Inc. (NYSEAMERICAN:RFL) and Revance Therapeutics Inc. (NASDAQ:RVNC) as far as analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation are concerned. The two businesses are rivals in the Biotechnology industry. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings […]

Diffusion Pharmaceuticals Inc. (DFFN)’s Financial Results Comparing With uniQure N.V. (NASDAQ:QURE)

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) and uniQure N.V. (NASDAQ:QURE), are influenced by contrast since they are both players in the Biotechnology. These factors are particularly influence the institutional ownership, profitability, risk, analyst recommendations, dividends, earnings and valuation of the two firms. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings […]

Contrasting of Northern Technologies International Corporation (NTIC) and GCP Applied Technologies Inc. (NYSE:GCP)

Northern Technologies International Corporation (NASDAQ:NTIC) and GCP Applied Technologies Inc. (NYSE:GCP) have been rivals in the Specialty Chemicals for quite some time. Below is a review of each business including various aspects such as risk, analyst recommendations, profitability, institutional ownership, dividends, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales […]

Chesapeake Energy Corporation (CHK)’s Financial Results Comparing With Magnolia Oil & Gas Corporation (NYSE:MGY)

Chesapeake Energy Corporation (NYSE:CHK) and Magnolia Oil & Gas Corporation (NYSE:MGY) have been rivals in the Independent Oil & Gas for quite some time. Below is a review of each business including various aspects such as profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation. Valuation & Earnings Gross […]